Trials / Completed
CompletedNCT00167869
LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 135 (planned)
- Sponsor
- Wageningen University · Academic / Other
- Sex
- All
- Age
- 35 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | dairy peptides |
Timeline
- Start date
- 2004-06-01
- Primary completion
- 2005-06-01
- Completion
- 2005-06-01
- First posted
- 2005-09-14
- Last updated
- 2008-05-29
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00167869. Inclusion in this directory is not an endorsement.